机译:卡铂联合伊立替康联合化疗在复发性前列腺小细胞癌并发脑膜癌的患者中显示出良好的疗效
Kanazawa University Hospital Cancer Center 13-1 Takara-machi Kanazawa 920-8641 Japan;
Kanazawa University Hospital Cancer Center 13-1 Takara-machi Kanazawa 920-8641 Japan;
Kanazawa University Hospital Cancer Center 13-1 Takara-machi Kanazawa 920-8641 Japan;
Kanazawa University Hospital Cancer Center 13-1 Takara-machi Kanazawa 920-8641 Japan;
Kanazawa University Hospital Cancer Center 13-1 Takara-machi Kanazawa 920-8641 Japan;
Kanazawa University Hospital Cancer Center 13-1 Takara-machi Kanazawa 920-8641 Japan;
Department of Human Pathology Kanazawa University Graduate School of Medical Science Kanazawa Japan;
Kanazawa University Hospital Cancer Center 13-1 Takara-machi Kanazawa 920-8641 Japan;
Kanazawa University Hospital Cancer Center 13-1 Takara-machi Kanazawa 920-8641 Japan;
Prostate; Small cell carcinoma; Chemotherapy; Meningeal carcinomatosis; ProGRP; Refractory case;
机译:卡铂联合伊立替康联合化疗对复发性前列腺小细胞癌并发脑膜癌的患者显示出良好的疗效。
机译:鞘内MTX / Ara-C联合全身化学疗法治疗胃癌脑膜癌的疗效
机译:鞘内MTX / Ara-C联合全身化学疗法治疗胃癌脑膜癌的疗效
机译:腹腔灌注热化学疗法(CHIP)联合顺铂联合静脉化疗治疗晚期胃肠道癌的疗效
机译:免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性:RU051417I-R-ICE(利妥昔单抗-异环磷酰胺-卡铂-依托泊苷)与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤(DLBCL)。
机译:PD-035二线伊立替康为基础的化疗在辅助化疗后早期复发的胃癌患者中的疗效和安全性:TRICS试验的探索性亚组分析
机译:卡铂联合伊立替康联合化疗对前列腺复发性小细胞癌合并脑膜癌病患者有良好疗效